Pfizer will request the authorization of its vaccine against COVID-19 for children between 6 months and 5 years
2022-02-01T19:42:45.385Z
The pharmaceutical company announced that it will soon submit to the FDA the proposal for immunization of two doses of its vaccine for this group, which could take place at the end of February. If approved for emergency use, it will benefit 19 million children.
Similar news:
- Covid-19: Pfizer will seek authorization for its vaccine for children under 5 in the United States 2 years
- Pfizer would request emergency use of its vaccine in children under 5 years of age 2 years
- Pfizer-BioNTech seeks authorization of the COVID-19 vaccine for children under 5 years of age 2 years
- Pfizer and BioNTech request vaccine authorization for children under 5 years of age 2 years
- Pfizer asks the FDA to authorize its vaccine against COVID-19 in children under 5 years of age 2 years
- Pfizer requests an authorization that brings the vaccine against COVID-19 closer to children aged 6 months to 5 years 2 years
